Estrogen, tamoxifen, and Akt modulate expression of putative housekeeping genes in breast cancer cells

详细信息    查看全文

• 作者：Khyati N. Shah^a ; Jesika S. Faridi ; ^a ; ^{jfaridi@pacific.edu"" rel=""nofollow}
• 关键词：Akt ; Estrogen ; MCF-7 ; Reference gene ; RT-qPCR ; Tamoxifen
• 刊名：The Journal of Steroid Biochemistry and Molecular Biology
• 出版年：2011
• 出版时间：July 2011
• 年：2011
• 卷：125
• 期：3-5
• 页码：219-225
• 全文大小：391 K

文摘

Clinically, Akt overexpression has been associated with tamoxifen resistance, and multiple in vitro breast cancer models of tamoxifen resistance have been developed. In order to study the mechanism of this tamoxifen resistance, differential gene expression studies have been performed utilizing quantitative reverse transcription-polymerase chain reaction (RT-qPCR). Since accurate data normalization requires the use of a stable reference gene, the goal of this study was to identify the most stable reference gene for RT-qPCR (from a panel of putative housekeeping genes) that remains unaltered despite estrogen or tamoxifen treatment or stable overexpression of active Akt. Gene expression of nine candidate genes was determined in parental and Akt overexpressing MCF-7 breast cancer cells treated with estrogen, tamoxifen, or vehicle, and gene stability was analyzed using two different statistical models. Based on our results, we suggest RPL13A as suitable internal reference gene that is both stable and remains unaltered in MCF-7 cells regardless of estrogen or tamoxifen treatment or Akt overexpression. We also validated that expression levels for RPL13A, as well as RPLP0 (another member of the RPL protein family), remain unaltered after estrogen and tamoxifen treatment in the ER positive ZR-75-1 cell line and ER negative MDA-MB-468 breast cancer cell line. Both RPL13A and RPLP0 levels were also stable in normal and tumor mammary tissue from Her2 overexpressing mice. In addition, our work emphasizes the importance of a preliminary study to validate each reference gene that will be used for RT-qPCR.